Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | MMP14 | P50281 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | SLC19A2 | O60779 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3479723 | 0.98 | KDM4E (0.53) | SMN1; SMN2NPC1POLBRAB9AKDM4E | |
| Bromide SCHEMBL15546500 | 0.98 | SMN1; SMN2 (0.55) | SMN1; SMN2NPC1POLBRAB9AKDM4E | |
| Iodide SCHEMBL3433717 | 0.98 | SMN1; SMN2 (0.50) | SMN1; SMN2NPC1POLBRAB9AKDM4E | |
| SCHEMBL11004427 | 0.79 | KDM4E (0.46) | SMN1; SMN2NPC1POLBRAB9AKDM4E | |
| SCHEMBL3087633 | 0.78 | KDM4E (0.44) | SMN1; SMN2NPC1POLBRAB9AKDM4E | |
| SCHEMBL11004432 | 0.77 | KDM4E (0.43) | SMN1; SMN2NPC1POLBRAB9AKDM4E | |
| SCHEMBL8922515 | 0.76 | SMN1; SMN2 (0.48) | SMN1; SMN2NPC1POLBRAB9AKDM4E | |
| SCHEMBL4981749 | 0.75 | KDM4E (0.42) | SMN1; SMN2NPC1POLBRAB9AKDM4E | |
| SCHEMBL721593 | 0.75 | HDAC8 (0.50) | SMN1; SMN2NPC1POLBRAB9AKDM4E | |
| SCHEMBL11286540 | 0.75 | KDM4E (0.42) | SMN1; SMN2NPC1POLBRAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122051358-A | Gel polymer solid electrolyte membrane, preparation method thereof and application thereof in sodium metal battery | 浙江钠创新能源有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-10357751-B2 | Polymer micelles containing nanoparticles in non-aqueous solution, methods for their preparation and use | FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2019-07-23 | — | — | US | claimed |
| US-10315178-B2 | Polymer micelles containing nanoparticles in non-aqueous solution, methods for their preparation and use | FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2019-06-11 | — | — | US | claimed |
| US-20170225141-A1 | POLYMER MICELLES CONTAINING NANOPARTICLES IN NON-AQUEOUS SOLUTION, METHODS FOR THEIR PREPARATION AND USE | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2017-08-10 | — | — | US | claimed |
| US-20170225140-A1 | POLYMER MICELLES CONTAINING NANOPARTICLES IN NON-AQUEOUS SOLUTION, METHODS FOR THEIR PREPARATION AND USE | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2017-08-10 | — | — | US | claimed |
| EP-2953930-B1 | PROCESSES FOR PREPARING 1-ALKYL-3-ALKYL-PYRIDINIUM BROMIDE AND USES THEREOF AS ADDITIVES IN ELECTROCHEMICAL CELLS | BROMINE COMPOUNDS LTD (IL) | 2016-12-07 | — | — | EP | claimed |
| US-20110015245-A1 | BENDAMUSTINE AMPHIPHILIC CATIONIC COMPOSITIONS | SUPRATEK PHARMA INC. (CA) | 2011-01-20 | — | — | US | claimed |
| CN-122051358-A | Gel polymer solid electrolyte membrane, preparation method thereof and application thereof in sodium metal battery | 浙江钠创新能源有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20240148696-A1 | LYOPHILIZED BENDAMUSTINE-CYCLODEXTRIN COMPOSITION | SOFTKEMO PHARMA INC. (CA) | 2024-05-09 | — | — | US | disclosed |
| WO-2024091826-A1 | LYOPHILIZED BENDAMUSTINE-CYCLODEXTRIN COMPOSITION | SOFTKEMO PHARMA INC. (CA) | 2024-05-02 | — | — | WO | disclosed |
| US-20200368355-A1 | FORMULATIONS OF BENDAMUSTINE | EAGLE PHARMACEUTICALS, INC. (US) | 2020-11-26 | — | — | US | disclosed |
| US-10357751-B2 | Polymer micelles containing nanoparticles in non-aqueous solution, methods for their preparation and use | FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2019-07-23 | — | — | US | disclosed |
| US-10315178-B2 | Polymer micelles containing nanoparticles in non-aqueous solution, methods for their preparation and use | FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2019-06-11 | — | — | US | disclosed |
| US-20130190372-A1 | BENDAMUSTINE CYCLOPOLYSACCHARIDE COMPOSITIONS | SUPRATEK PHARMA INC. (CA) | 2013-07-25 | — | — | US | disclosed |
| US-8436032-B2 | Bendamustine cyclopolysaccharide compositions | SUPRATEK PHARMA INC. (CA) | 2013-05-07 | — | — | US | disclosed |
| WO-2013042110-A1 | ADDITIVES FOR HYDROGEN/ BROMINE CELLS | BROMINE COMPOUNDS LTD. (IL) | 2013-03-28 | — | — | WO | disclosed |
| WO-2011104625-A1 | CYCLOPOLYSACCHARIDE COMPOSITIONS | SUPRATEK PHARMA, INC. (CA) | 2011-09-01 | — | — | WO | disclosed |
| US-20110015245-A1 | BENDAMUSTINE AMPHIPHILIC CATIONIC COMPOSITIONS | SUPRATEK PHARMA INC. (CA) | 2011-01-20 | — | — | US | disclosed |
| US-20100216858-A1 | BENDAMUSTINE CYCLOPOLYSACCHARIDE COMPOSITIONS | SOFTKEMO PHARMA CORP. (CA) | 2010-08-26 | — | — | US | disclosed |
| US-4272620-A | Polyvinyl alcohol-styrylpyridinium photosensitive resins and method for manufacture thereof | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1981-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200368355-A1 | FORMULATIONS OF BENDAMUSTINE | FOLR2, BHMT, THPO | SMN1; SMN2 190/4885NPC1 958/4885POLB 1488/4885 |
| US-20240148696-A1 | LYOPHILIZED BENDAMUSTINE-CYCLODEXTRIN COMPOSITION | SORD, SBK1, SBDS | SMN1; SMN2 505/4885NPC1 1812/4885POLB 4574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.